Preliminary findings in an eagerly awaited parliamentary report into the 2023 collapse of Credit Suisse have identified serious failings by Swiss regulatory authorities leading up the bank's demise, a
Gold prices have surged in 2024 and judging by the latest analyst commentary, this trend is unlikely to stop anytime soon. UBS (NYSE: UBS ) updated its gold price forecasts recently, raising its expec
One of the features of this stock-market run, which on Wednesday carried the S&P 500 SPX to its 37th record high of the year, is just how much complacency there is, as measured by low readings of impl
Some stocks fly under the radar of investors even as they quietly dominate the industry in which they operate. These stealth stocks rise to the top by developing competitive advantages.
WATERTOWN, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targete
Nvidia (NVDA) shares edge higher Monday as analysts from UBS and Wolfe Research raise their price targets on the chip stock to $150 per share. Market Domination's Josh Lipton and Julie Hyman talk abou
UBS analysts on Monday called Bank of America Corp. the “most interesting money center,” as major banks approach second-quarter earnings season later this week.
NVIDIA Corp (NASDAQ:NVDA, ETR:NVD) was a key driving force on Wall Street on Monday after UBS upped its target price, based on supply chain checks. Investor sentiment about the chip giant “has fade

UBS upgrades PNC Financial to buy

11:50am, Monday, 08'th Jul 2024
Erika Najarian, UBS large cap bank and consumer finance analyst, joins 'Squawk on the Street' to discuss how to pick the winners among the financials, why Najarian favors PNC, and more.
Nvidia Corp.'s stock is still well-loved on Wall Street, but UBS analyst Timothy Arcuri notes that sentiment “has faded somewhat in recent weeks.”
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ann
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day.
Credit Suisse's collapse was caused by the bank's management, not by Swiss financial authorities, Swiss National Bank Chairman Thomas Jordan was quoted as saying on Friday.
Direct Line Insurance Group PLC's (LSE:DLG) capital markets day on Wednesday, July 10, will see a focus on three areas according to UBS, with dividends likely to be central to the discussion. “We an
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE